The role of CtIP (RBBP8) in tamoxifen resistance and human breast cancer
dc.contributor.advisor | Aldaz, C. Marcelo | en |
dc.contributor.advisor | Richburg, John H. | en |
dc.creator | Wu, Minhao | en |
dc.date.accessioned | 2008-08-28T23:18:19Z | en |
dc.date.accessioned | 2017-05-11T22:17:37Z | |
dc.date.available | 2008-08-28T23:18:19Z | en |
dc.date.available | 2017-05-11T22:17:37Z | |
dc.date.issued | 2007 | en |
dc.description | text | en |
dc.description.department | Pharmacy | en |
dc.format.medium | electronic | en |
dc.identifier | b68639405 | en |
dc.identifier.oclc | 166275571 | en |
dc.identifier.uri | http://hdl.handle.net/2152/2951 | en |
dc.language.iso | eng | en |
dc.rights | Copyright is held by the author. Presentation of this material on the Libraries' web site by University Libraries, The University of Texas at Austin was made possible under a limited license grant from the author who has retained all copyrights in the works. | en |
dc.subject.lcsh | Tamoxifen | en |
dc.subject.lcsh | Breast--Cancer--Treatment | en |
dc.title | The role of CtIP (RBBP8) in tamoxifen resistance and human breast cancer | en |
dc.type.genre | Thesis | en |